People · Operator

W. DEAN BAKER

Named in public records as an officer, director or promoter · active 2009–2017 · Other, Biotechnology

2
Companies
26
Filings
$98.4M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Nanoprecision Holding Co IncOtherSeries A$76.2M$105.9M2009
Nano Precision Medical, Inc.BiotechnologySeries A$22.1M$206.7M2011
Operator network

W. DEAN BAKER at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

AARON DEAN MENDELSOHN · 1 companies · 1 sharedAARON DEAN MENDEL…JOSHUA DEAN MENDELSOHN · 1 companies · 1 sharedJOSHUA DEAN MENDE…MARC PAUL JACOBS · 1 companies · 1 sharedMARC PAUL JACOBSMICHAEL DEAN BARNOSKI · 1 companies · 1 sharedMICHAEL DEAN BARN…MICHAEL PAUL BARNOSKI · 1 companies · 1 sharedMICHAEL PAUL BARN…Adam Mendelsohn · 3 companies · 1 sharedAdam MendelsohnAaron Mendelsohn · 2 companies · 1 sharedAaron MendelsohnKathleen Fischer · 1 companies · 1 sharedKathleen FischerKathleen Fisher · 1 companies · 1 sharedKathleen FisherLILY DEAN PENG · 1 companies · 1 sharedLILY DEAN PENGLily Peng · 1 companies · 1 sharedLily PengNanoprecision Holding Co Inc · $76.2M raisedNanoprecision Holding…Nano Precision Medical, Inc. · $22.1M raisedNano Precision Medica…W. DEAN BAKERWB
W. DEAN BAKER Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside W. DEAN BAKER on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Adam Mendelsohn13
Aaron Mendelsohn12
AARON DEAN MENDELSOHN11
JOSHUA DEAN MENDELSOHN11
MARC PAUL JACOBS11
MICHAEL PAUL BARNOSKI11
Kathleen Fischer11
Lily Peng11
LILY DEAN PENG11
Kathleen Fisher11
MICHAEL DEAN BARNOSKI11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.